[Form 4] SONOCO PRODUCTS CO Insider Trading Activity
Rhea-AI Filing Summary
Sonoco Products Company director Blythe J. McGarvie reported a change in deferred equity holdings. On 01/02/2026, McGarvie acquired 817 phantom stock units at $44.37 per unit under Sonoco’s directors deferred compensation plan. Following this transaction, McGarvie beneficially owns 32,587.8 phantom stock units, held directly.
Each phantom stock unit is the economic equivalent of one share of Sonoco Products Company common stock. Under the plan, these phantom stock units are scheduled to be settled in Sonoco common stock six months after the director’s retirement, aligning director compensation with long-term shareholder interests.
Positive
- None.
Negative
- None.
FAQ
What insider transaction did Sonoco Products (SON) report in this Form 4?
The filing reports that director Blythe J. McGarvie acquired 817 phantom stock units of Sonoco Products Company on 01/02/2026 under a deferred compensation plan.
How many phantom stock units does Blythe J. McGarvie now hold in Sonoco Products (SON)?
After the reported transaction, Blythe J. McGarvie beneficially owns 32,587.8 phantom stock units of Sonoco Products Company, held directly.
What is the value basis of the new Sonoco phantom stock units reported?
The 817 phantom stock units were reported with a transaction price of $44.37 per unit.
What are phantom stock units in the Sonoco Products (SON) director plan?
Each phantom stock unit is the economic equivalent of one share of Sonoco Products Company common stock and tracks the value of the underlying shares.
When will the Sonoco phantom stock units be settled into common stock?
The phantom stock units accrued under the directors deferred compensation plan are to be settled in Sonoco common stock six months after the director’s retirement.
Is this Sonoco Products insider Form 4 filed for one reporting person or a group?
The document indicates that the Form 4 is filed by one reporting person, not by a group.